ADCs or: How I learned to stop worrying and love chemotherapy Editorial

  


Authors: Gupta, A.; Drago, J. Z.; Chandarlapaty, S.
Title: ADCs or: How I learned to stop worrying and love chemotherapy
Abstract: Antibody-drug conjugates are transforming cancer treatment, and payload characteristics are emerging as crucial determinants of clinical activity. As exemplified by Weng and colleagues, advancements in the linker and payload chemistry may provide the next evolutionary step in enabling this class of drugs to overcome chemoresistance and deliver even more profound responses. See related article by Weng et al., p. 950 (2). ©2023 American Association for Cancer Research.
Keywords: lung neoplasms; lung tumor; exatecan; colon; antibody conjugate; immunoconjugates; love; humans; human
Journal Title: Cancer Discovery
Volume: 13
Issue: 4
ISSN: 2159-8274
Publisher: American Association for Cancer Research  
Date Published: 2023-04-01
Start Page: 817
End Page: 818
Language: English
DOI: 10.1158/2159-8290.Cd-23-0091
PUBMED: 37009702
PROVIDER: scopus
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85151387506&doi=10.1158%2f2159-8290.CD-23-0091&partnerID=40&md5=3dd0699c1e3ba3bdb1e45b16d18937c7
Notes: Export Date: 1 May 2023 -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Sarat Chandarlapaty
    277 Chandarlapaty
  2. Joshua Drago
    27 Drago
  3. Avantika Gupta
    5 Gupta
Related MSK Work